Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer

Pratima Nangia-Makker; Yingjie Yu; Anita Vasudevan; Lulu Farhana; Sindhu G. Rajendra; Edi Levi; Adhip P. N. Majumdar

doi:10.1371/journal.pone.0084369

Loading metrics

Open Access

Peer-reviewed

Research Article

Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer

Pratima Nangia-Makker,

Affiliations Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States of America, Department of Internal Medicine, Wayne State University, Detroit, Michigan, United States of America
⨯
Yingjie Yu,

Affiliations Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America, Department of Internal Medicine, Wayne State University, Detroit, Michigan, United States of America
⨯
Anita Vasudevan,

Affiliations Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America, Department of Internal Medicine, Wayne State University, Detroit, Michigan, United States of America
⨯
Lulu Farhana,

Affiliations Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America, Department of Internal Medicine, Wayne State University, Detroit, Michigan, United States of America
⨯
Sindhu G. Rajendra,

Affiliation Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America
⨯
Edi Levi,

Affiliation Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America
⨯
Adhip P. N. Majumdar

* E-mail: a.majumdar@wayne.edu

Affiliations Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan, United States of America, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States of America, Department of Internal Medicine, Wayne State University, Detroit, Michigan, United States of America
⨯

Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer

Pratima Nangia-Makker,
Yingjie Yu,
Anita Vasudevan,
Lulu Farhana,
Sindhu G. Rajendra,
Edi Levi,
Adhip P. N. Majumdar

Published: January 20, 2014
https://doi.org/10.1371/journal.pone.0084369

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.